Clinical Trial: Single Ascending Dose and Multiple Ascending Dose Evaluation of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MDI-2517 in Healthy Participants

U.S., Oct. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07220889) titled 'Single Ascending Dose and Multiple Ascending Dose Evaluation of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MDI-2517 in Healthy Participants' on Oct. 19.

Brief Summary: The goal of this clinical trial is to learn if drug MDI2517 is safe and to learn more about its drug effects in healthy participants. Healthy participants will take single or multiple doses of drug and the safety and drug levels will be measured.

Study Start Date: Nov. 04

Study Type: INTERVENTIONAL

Condition: Safety After Oral Intake

Intervention: DRUG: MDI-2517 800mg

800mg MDI-2517 will be administered

OTHER: Placebo

Matching Placebo

DR...